First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec ... between glyphosate exposure in mice and symptoms of neuroinflammation, as well as accelerated ...
Some research shows it may have benefits for people with Alzheimer’s disease, but current evidence ... certain times of of day may help improve symptoms of sundowning syndrome.
On track to report data from Phase 1 clinical trial evaluating VG-3927 for Alzheimer’s disease in 1Q 2025, providing critical insights into treatment options. Final analysis from IGNITE Phase 2 ...